Exploring the Vaccine Conundrum: Little Profit, Much Risk

April 2, 2007
As vaccine manufacturing guru Don Gerson summed it up in an article we'd published a few years ago, "Why should I give you a lifetime of protection against a dangerous disease for the price of a Big Mac or two?" Vaccines are such an important area of drug research, yet extremely risky and often unprofitable.� An excellent article in The Scientist today explores the issue and potential solutions
As vaccine manufacturing guru Don Gerson summed it up in an article we'd published a few years ago, "Why should I give you a lifetime of protection against a dangerous disease for the price of a Big Mac or two?" Vaccines are such an important area of drug research, yet extremely risky and often unprofitable.� An excellent article in The Scientist today explores the issue and potential solutions
About the Author

pharmamanufacturing | pharmamanufacturing